The PREVENA RESTOR™ Therapy portfolio optimizes post-operative care by delivering negative pressure therapy to the incision and surrounding soft tissue to enhance recovery ST. PAUL, Minn.--(BUSINESS ...
Research presented at the 30th American Association of Hip and Knee Surgeons Annual Meeting (AAHKS) builds on existing evidence that PREVENA™ Therapy lowers surgical site complications and readmission ...
CLEVELAND--(BUSINESS WIRE)--Aatru Medical, LLC ("Aatru") today announced the successful completion of the first 14 patients in their multi-center New Zealand-based clinical study of the FDA-approved ...
Aatru Medical LLC has received FDA 510(k) class II clearance for a platform that turns its back on electro-mechanical components in other negative pressure wound therapy (NPWT) systems. Deployed for ...
ST. PAUL, Minn.--(BUSINESS WIRE)--3M today announced new data demonstrating the PREVENA™ Incision Management System significantly mitigated 90-day surgical site complications (SSCs) and readmission ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results